If you are a man with BPH (enlarged prostate) who has been told by a urologist that surgery is the next step, you have likely encountered two procedure names TURP (Transurethral Resection of the Prostate) and HoLEP (Holmium Laser Enucleation of the Prostate). Both are performed through the urethra without any skin incision. Both treat BPH effectively.
Both are offered at KIMS Secunderabad which is why this comparison can be genuinely objective. At a centre that only performs one of these procedures, the recommendation is not a comparison it is a default. At KIMS, where TURP, HoLEP, and TULSA-PRO are all available, the recommendation is based on which procedure is actually most appropriate for your specific prostate, your symptoms, and your priorities.
This post compares TURP and HoLEP across every dimension that matters to a patient making this decision: prostate size suitability, symptom improvement, retreatment rates, blood loss, catheter duration, hospital stay, ejaculation, and long-term outcomes. It is written to give you the information to have an informed conversation with your urologist not to replace that conversation, but to prepare you for it.
TURP (Transurethral Resection of the Prostate) has been the standard surgical treatment for BPH for more than 40 years. A resectoscope — a rigid endoscope with an electrically heated cutting loop — is passed through the urethra. The surgeon systematically shaves away the obstructing central zone of the prostate adenoma in successive passes, removing chips of tissue that are irrigated out of the bladder.
The process is systematic but partial — TURP removes the obstructing core of the prostate while leaving the peripheral zone and the outer prostatic capsule intact. Because it is a partial resection, some adenoma tissue remains and can continue to grow, explaining the 15% retreatment rate at 5 years.
At KIMS: We use the bipolar technique with saline irrigation, eliminating the risk of TUR syndrome associated with older monopolar methods.
HoLEP (Holmium Laser Enucleation of the Prostate) is a fundamentally different procedure. Rather than cutting through the adenoma with a loop, a 100W Holmium laser is used to develop the anatomical plane between the obstructing adenoma and the outer prostatic capsule.
The entire adenoma is dissected free, pushed into the bladder, morcellated (chopped), and removed. This anatomical completeness drives a superior retreatment rate of under 2% at 5 years. There is no residual tissue left to regrow.
At KIMS: HoLEP is performed by surgeons with specific high-volume training in laser enucleation and morcellation, ensuring precision in this technically demanding procedure.
| Factor | TURP (Bipolar at KIMS) | HoLEP (100W at KIMS) | TULSA-PRO |
|---|---|---|---|
| What is removed | Central obstructing core — partial resection, peripheral zone and capsule preserved. | Entire adenoma — complete enucleation from the prostatic capsule, equivalent to open prostatectomy through the urethra. | Targeted ablation of the obstructing prostate tissue using MRI-guided ultrasound. |
| Best prostate size | Best for 30–80cc. Risk of incomplete resection rises above 80cc. | Any size including 300cc+. No size limit. | Typically <100cc with specific MRI anatomy. |
| 5-year retreatment rate | ~15% — residual tissue continues to grow after partial resection. | <2% — complete removal leaves no residual tissue to regrow. | ~10–15% (emerging data). |
| Blood loss | Moderate — resection surface bleeds until bipolar coagulation achieves haemostasis. | Virtually nil — Holmium laser achieves haemostasis as it cuts. Safe on anticoagulation. | None — incisionless procedure. |
| Hospital stay | 2–3 nights | 1–2 nights | Same day or next morning |
| Catheter duration | 48–72 hours | Typically 24 hours | Several days |
| Anticoagulation safety | Manageable — requires bridging planning. | Excellent — preferred BPH surgery for anticoagulated patients. | Excellent — non-surgical. |
| Available at KIMS | Yes — bipolar saline (current international standard). | Yes — surgeons with specific laser enucleation volume. | Yes — India's only centre. |
TURP is not a second-class option. For the right patient, it is an excellent procedure with a 40-year evidence base and well-characterised outcomes. TURP at KIMS is the most appropriate choice when:
In this range, TURP delivers equivalent symptom improvement to HoLEP with a simpler and typically faster procedure.
Median lobe hypertrophy obstructing the bladder neck is efficiently addressed by TURP resection.
For patients where limiting anaesthesia duration is a priority due to significant medical comorbidities, TURP on smaller glands is typically faster.
Bladder neck contracture, small bladder stones, or diverticula can be managed simultaneously in a single TURP session.
A valid choice for a patient who understands the retreatment rate difference and prefers a faster, simpler procedure.
HoLEP represents a significant technological leap in prostate surgery. At KIMS, it is the definitive gold-standard approach for patients where completeness of removal and surgical safety are the primary objectives:
HoLEP is the definitive procedure for large glands. It replaces open prostatectomy for very large prostates (150cc to 300cc+) — providing the same complete adenoma removal through the urethra, without an abdominal incision.
For patients choosing between TURP (15% retreatment at 5 years) and HoLEP (under 2%) for a prostate of any size, HoLEP offers the most compelling reason to ensure the obstruction is resolved permanently.
Whether on warfarin, apixaban, rivaroxaban, or clopidogrel, HoLEP's superior laser haemostasis makes it the safest BPH surgery for patients who must remain on blood thinners.
A patient with a 150cc prostate causing urinary retention who has been told they need open surgery elsewhere can be treated entirely endoscopically with HoLEP at KIMS.
For patients who have already had a TURP but are experiencing regrowth or failed results, HoLEP is the most effective surgical option for clearing the remaining tissue mass.
TURP and HoLEP are surgical treatments for BPH. A third option available in India only at KIMS Secunderabad is TULSA-PRO (Transurethral Ultrasound Ablation): MRI-guided, incision-free, no general anaesthesia required in most cases, same-day discharge. TULSA-PRO is the only BPH treatment with significantly better ejaculation preservation than either TURP or HoLEP making it the preferred option for men where preserving ejaculation is a high priority. For men with localised prostate cancer who are also candidates for BPH treatment, TULSA-PRO can address both simultaneously.
Because KIMS offers TURP, HoLEP, and TULSA-PRO, the recommendation at a KIMS BPH consultation is genuinely objective. The urologist discusses all three options, their trade-offs, and makes a specific recommendation based on your prostate size, anatomy, anticoagulation status, and your own stated priorities. You will leave the consultation understanding why one procedure is recommended for you specifically not because it is the only one the surgeon performs.
For most patients where HoLEP is technically appropriate, HoLEP produces better long-term outcomes than TURP — specifically, a retreatment rate of under 2% at 5 years versus TURP's approximately 15%. This difference is clinically and economically significant: a 1-in-7 chance of needing repeat surgery within 5 years, compared to a 1-in-50 chance. For large prostates above 80cc, HoLEP is unambiguously superior — TURP is technically limited by size, while HoLEP has no size limit. For prostate volumes of 30 to 80cc, TURP remains an excellent procedure with equivalent symptom outcomes to HoLEP and a well-established evidence base. The right answer depends on your specific prostate size, your priorities, and whether you value lower retreatment risk over shorter procedure time.
Yes — at KIMS, a 120cc prostate (or larger) can be treated with HoLEP without any abdominal incision. HoLEP uses the same anatomical enucleation plane as open simple prostatectomy, but performed entirely through the urethra using a Holmium laser. KIMS performs HoLEP on prostates of 150cc, 200cc, and larger — which other centres decline for endoscopic surgery and refer for open prostatectomy. Open prostatectomy requires a lower abdominal incision, a 5 to 7 day hospital stay, and 6 to 8 weeks of recovery. HoLEP at KIMS for the same gland size delivers catheter removal at 24 hours and hospital discharge at 1 to 2 nights.
HoLEP produces durable, long-lasting results because it removes the entire obstructing adenoma from within the prostatic capsule — there is no residual adenoma tissue to regrow. Published series with 5 to 10 year follow-up confirm retreatment rates of under 2% and sustained IPSS and uroflowmetry improvement. The prostatic capsule that remains after HoLEP does not produce obstructing tissue in the same way the adenoma did. TURP, by contrast, leaves residual adenoma tissue that can regrow over years — explaining the 15% retreatment rate at 5 years. For a 50-year-old man with a 30-year life expectancy after surgery, the cumulative retreatment probability with TURP over that period significantly exceeds the equivalent probability with HoLEP.
Retrograde ejaculation — semen travelling backwards into the bladder during orgasm rather than forward — occurs in approximately 75% of men after both TURP and HoLEP. This is because both procedures disrupt the bladder neck mechanism that normally propels semen forward. Retrograde ejaculation is harmless — the semen mixes with urine and passes out in the next void. It does not affect erection, libido, or the sensation of orgasm. Men who wish to father children after either procedure should discuss sperm banking before surgery. For men where any change to ejaculation is unacceptable, TULSA-PRO at KIMS — India's only centre — offers significantly better ejaculation preservation than either surgical option.
HoLEP is significantly safer than TURP for patients on anticoagulation (warfarin, apixaban, rivaroxaban, dabigatran, clopidogrel). The Holmium laser achieves haemostasis simultaneously as it cuts — the laser seals the small blood vessels in the enucleation plane. This intrinsic haemostasis makes HoLEP blood loss essentially independent of anticoagulation status. At KIMS, anticoagulated patients requiring BPH surgery are routinely assessed for HoLEP rather than TURP, with anticoagulation management coordinated with the treating cardiologist or physician.
The key differences in the immediate post-operative period: catheter removal is at 48 to 72 hours for TURP versus 24 hours for HoLEP. Hospital stay is 2 to 3 nights for TURP versus 1 to 2 nights for HoLEP. Return to desk work is similar — 2 to 3 weeks for both. Return to strenuous activity is 4 to 6 weeks for both. A temporary flare of haematuria (visible blood in urine) at 10 to 14 days post-operatively — when the post-surgical scab separates — is common to both TURP and HoLEP and should not cause alarm. Temporary urgency and frequency during the healing phase (2 to 6 weeks) is also common to both.
KIMS Secunderabad — the only hospital in Hyderabad offering TURP, HoLEP, and TULSA-PRO as a genuine three-option programme, with objective recommendation based on each patient's specific prostate and priorities. Bipolar TURP with saline irrigation (TUR syndrome eliminated). 100W HoLEP with no size limit. TULSA-PRO India's only centre. Dr. Neil Narendra Trivedi — MCh Urology KEM Hospital Mumbai, member SIU and USI, 1,000+ procedures. NABH accredited. Aarogyasri, CGHS, EHS empanelled. Call 040 - 44885000.